Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Up 19.9% in July

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totalling 492,300 shares, a growth of 19.9% from the June 30th total of 410,600 shares. Currently, 1.6% of the company’s stock are short sold. Based on an average daily volume of 54,600 shares, the days-to-cover ratio is currently 9.0 days.

Analyst Upgrades and Downgrades

BIOX has been the subject of a number of research reports. Roth Mkm began coverage on shares of Bioceres Crop Solutions in a report on Tuesday, July 2nd. They issued a “buy” rating and a $15.00 price objective for the company. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Canaccord Genuity Group reiterated a “buy” rating and issued a $17.00 price objective on shares of Bioceres Crop Solutions in a research note on Friday, July 19th. Finally, Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a report on Tuesday, July 2nd. Three analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $19.00.

Bioceres Crop Solutions Stock Down 0.6 %

NASDAQ BIOX traded down $0.07 on Tuesday, hitting $10.93. 20,026 shares of the stock were exchanged, compared to its average volume of 58,235. Bioceres Crop Solutions has a fifty-two week low of $10.10 and a fifty-two week high of $14.05. The company has a 50-day moving average price of $10.99 and a 200-day moving average price of $12.16. The company has a quick ratio of 0.83, a current ratio of 1.22 and a debt-to-equity ratio of 0.29. The company has a market cap of $686.40 million, a PE ratio of 1,093.00 and a beta of 0.50.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its earnings results on Wednesday, May 29th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.02). The business had revenue of $83.98 million during the quarter, compared to analysts’ expectations of $88.80 million. Bioceres Crop Solutions had a net margin of 0.21% and a return on equity of 0.28%. Sell-side analysts anticipate that Bioceres Crop Solutions will post 0.35 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in BIOX. Activest Wealth Management purchased a new stake in Bioceres Crop Solutions during the first quarter worth approximately $30,000. Cape Investment Advisory Inc. acquired a new position in shares of Bioceres Crop Solutions in the 4th quarter valued at $33,000. Oppenheimer & Co. Inc. purchased a new position in shares of Bioceres Crop Solutions in the 1st quarter valued at $139,000. Lazard Asset Management LLC purchased a new stake in Bioceres Crop Solutions in the first quarter valued at $212,000. Finally, One Degree Advisors Inc purchased a new position in shares of Bioceres Crop Solutions during the fourth quarter worth about $291,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.